1.Methodology of Cancer Cell Culture and it's Clinical Application.
Journal of the Korean Pediatric Society 1986;29(5):15-22
No abstract available.
Cell Culture Techniques*
2.Histiocytosis Syndrome.
Korean Journal of Pediatrics 2004;47(Suppl 2):S468-S475
No abstract available.
Histiocytosis*
3.Results of Treatment in Children with Acute Lymphocytic Leukemia.
Journal of the Korean Pediatric Society 1986;29(12):59-97
No abstract available.
Child*
;
Humans
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
4.Results of Treatment in Children with Acute Lymphocytic Leukemia.
Journal of the Korean Pediatric Society 1986;29(12):59-97
No abstract available.
Child*
;
Humans
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
5.A Case of Congenital Hypoplastic Anemia.
Young Jong WOO ; Jae Sook MA ; Tai Ju HWANG
Journal of the Korean Pediatric Society 1983;26(2):188-192
No abstract available.
Anemia, Hypoplastic, Congenital*
6.A Epidemiologic Study of Malignant Tumors of Children in Chonnam Area.
Myong Hee KOOK ; Hys Ran MIN ; Tai Ju HWANG
Journal of the Korean Pediatric Society 1988;31(1):78-85
No abstract available.
Child*
;
Epidemiologic Studies*
;
Humans
;
Jeollanam-do*
8.Serum and Urine Zinc Values in Infectious Diseases.
Yong Tai SUH ; Hwa Young KIM ; Jai Sook MAH ; Tai Ju HWANG
Journal of the Korean Pediatric Society 1984;27(3):237-245
No abstract available.
Communicable Diseases*
;
Zinc*
9.Clinical observation of small for gestational age.
Young Zong OH ; Cheol Hee HWANG ; Young Youn CHOI ; Young Joung WOO ; Tai Ju HWANG
Journal of the Korean Pediatric Society 1991;34(1):41-48
No abstract available.
Gestational Age*
;
Mortality
10.Hematopoietic stem cell transplantation: overview for general pediatrician.
Korean Journal of Pediatrics 2007;50(7):613-621
Hematopoietic stem cell transplantation (HSCT) has expanded and evolved substantially in the last decades to treat various malignant and nonmalignant diseases. However, the conditioning regimen can lead to transplantation related death by major organ dysfunction, severe infection and bleeding. In the allogeneic setting, graft versus host disease may also develop, making post-transplant management complex. To overcome these problems, new stem cell sources, stem cell mobilizing agents and new skills, nonmyeloablative stem cell transplantation including reduced intensity stem cell transplantation has been introduced in clinical practice, but problems remained so far. Recipients of stem cell transplant may be severely immunocompromised for many months after transplantation. Furthermore, long- term complications (endocrine, metabolic, relapse, second malignancies, etc) can develop. Pediatrician is open called on to participate in the evaluation and consideration of patients for possible transplant and long-term follow-up of HSCT patients. This review is intended as a basic overview of HSCT relevant to general pediatrician.
Follow-Up Studies
;
Graft vs Host Disease
;
Hematopoietic Stem Cell Transplantation*
;
Hematopoietic Stem Cells*
;
Hemorrhage
;
Humans
;
Neoplasms, Second Primary
;
Recurrence
;
Stem Cell Transplantation
;
Stem Cells
Result Analysis
Print
Save
E-mail